• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

High-energy shockwave therapy effective in treating shoulder calcific tendinitis

byAimme Li, MDandKenan Celtik, MS
April 15, 2014
in Chronic Disease
Reading Time: 2 mins read
High-energy shockwave therapy effective in treating shoulder calcific tendinitis
Share on FacebookShare on Twitter

Image: GNUF/Wiki

1. In calcific tendinitis of the shoulder, high-energy extracorporeal shockwave therapy (ESWT) is associated with improvement shoulder function, pain and calcification. 

2. The effects of ESWT in noncalcific tendinitis and low energy ESWT in calcific tendinitis are inconclusive. 

Evidence Rating Level: 1 (Excellent)       

Study Rundown: Rotator cuff tendinitis is one of the most common causes of shoulder pain. Cases refractory to conservative therapies can be considered for surgical intervention. However, especially in cases of calcific tendinitis, there has been interest in ESWT (extra-corporal shockwave therapy) as a non-invasive alternative to surgery.  The efficacy of ESWT has been studied at various energy flux densities (EFD) to placebo in numerous clinical studies from Europe and Taiwan. This systematic review of 28 randomized control trials (RCTs) showed that high energy ESWT (EFD ≥0.28 mJ/mm2) was associated with improvements in shoulder function, pain and calcifications in calcific tendinitis when compared to placebo.  However, similar improvements were not associated with low energy ESWT (EFD <0.28 mJ/mm2).  Moreover, the effects of ESWT on noncalcific tendinitis were found to be inconclusive. Major limitation of this systematic review is the heterogeneity of the trials, including inconsistencies in the EFD categories and the variability in the patient populations used in each study.

Click to read the study, published today in the Annals of Internal Medicine

RELATED REPORTS

No Content Available

Relevant Reading: Shock Wave Therapy for Calcific Tendinitis of the Shoulder A Prospective Clinical Study with Two-Year Follow-up

In-Depth [systematic review]: This systematic review included 28 RCTs comparing high (EFD ≥0.28 mJ/mm2) and low-energy (<0.28 mJ/mm2) ESWT to placebo for treatment of calcific and non-calcific shoulder tendinitis. The 28 trials included 1745 patients with a mean age of 51 years, 3-12 months minimum duration of symptoms and on average 58% were women. Most of the trials were conducted in Europe, except for the 2 from Taiwan. The trials included in the study were generally of low quality and were highly heterogeneous. Sample sizes varied from 20-144 patients.  Only 6 trials were double0blinded, 3 trials had dropout rates >20%, intention to treat was used in only 14 studies and 14 different devices were used across the cohort of 28 included trials.  In the studies on calcific tendinitis, high energy ESWT significantly improved shoulder pain and function, compared to placebo. High energy ESWT proved significantly better than low energy ESWT at improving shoulder function and reducing calcification, but not at reducing pain.  The evidence regarding low energy ESWT and use of ESWT in non-calcific tendinitis was inconclusive.

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: calcific tendinitisHigh-energy shockwave therapy
Previous Post

Patients on accutane may not sufficiently educated regarding contraceptive choices

Next Post

Concomitant anticoagulant and NSAID/aspirin use linked with increased bleeding in venous thromboembolism

RelatedReports

No Content Available
Next Post

Concomitant anticoagulant and NSAID/aspirin use linked with increased bleeding in venous thromboembolism

High BMI linked to reduced risk of endometriosis

Increased maternal BMI linked to higher fetal, neonate, and infant mortality

Childhood migraine associated with infantile colic

¹⁸F-FDG PET brain imaging could predict recovery in vegetative patients

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Daraxonrasib extends survival in metastatic pancreatic cancer
  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
  • A lower threshold for referral to the emergency department for outpatient hyperkalemia may reduce mortality
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.